Nine Months, No Growth: How to Diagnose a Stalled VP Sales Hire Without Burning Down the Leadership Team
A VP Sales who hasn't moved the number in nine months is one of the most expensive ambiguities in a PE portfolio. The cost isn't just the salary — it's the compounding delay on an exit thesis that is already under pressure. With more than 18,000 portfolio companies stuck beyond traditional hold periods and 84% of PE fund managers reporting longer hold times, operating partners cannot afford to let this question sit unanswered for another quarter.
The diagnostic matters as much as the decision. Fire the wrong person and you inherit the same broken process with a new face. Keep the wrong person and you lose the runway to fix what's actually broken before the next LP review.
The Three-Fault Model: Separating Person, Process, and Market
Stalled growth after a senior sales hire almost always traces to one of three root causes — and they require completely different interventions.
Person fault: The hire lacks the specific motion required. A hunter who built a land-and-expand book at a PLG company is not automatically equipped to run a consultative, multi-stakeholder enterprise close. Competency in one motion does not transfer cleanly to another.
Process fault: The hire inherited a broken or absent system — no defined ICP, no repeatable qualification criteria, no handoff discipline between marketing and sales. Even a strong operator cannot manufacture consistent output from an undefined process.
Market fault: The segment, pricing, or positioning is structurally misaligned with what buyers will pay for. This is the hardest truth to surface because it implicates decisions made before the hire arrived.
The diagnostic error most operating partners make is sequencing the investigation wrong — they evaluate the person first because that's the most visible variable. Start with the system.
How to Run the Diagnostic Without Creating a Leadership Crisis
The goal is signal, not a performance review. Frame the work as a revenue architecture audit, not an evaluation of the VP. This framing matters because it's accurate — and because it keeps the leadership team functional while you gather data.
Four questions anchor the audit:
- Is there a defined ICP with documented firmographic and behavioral criteria, or is the team selling to anyone who will take a meeting? If the answer is the latter, the pipeline problem predates the hire.
- What does the stage-by-stage conversion data show? If deals are entering the pipeline but dying at a specific stage consistently, that's a process or positioning problem. If deals aren't entering at all, that's a demand or ICP problem. If deals close but don't expand or renew, that's a product-market fit or onboarding problem — and AI-native SaaS assets in particular are showing median NRR well below what most PE underwriting models assume, which means retention problems are hiding in plain sight across portfolios right now.
- What has the VP actually built versus inherited? Pull the artifact list: updated ICP definition, revised sales playbook, pipeline hygiene standards, rep coaching cadence. If nine months have passed and none of these exist, that is evidence about the hire. If they exist but aren't being executed, that's a management or resourcing problem.
- Has the market thesis been tested against real buyer behavior since the hire started? If the VP is executing against a positioning that was set before they arrived and no one has stress-tested it with current buyers, the market fault hypothesis deserves serious weight.
What the Data Should Tell You Before You Make a People Decision
A person fault is confirmed when: the VP cannot articulate a coherent ICP, has not produced any durable process artifacts, and conversion data shows no improvement trend in the stages they directly control — even in a small sample.
A process fault is confirmed when: the VP can articulate what good looks like, has attempted to build the system, but lacks the organizational support, clean data, or cross-functional alignment to execute it. This is more common than most operating partners expect, particularly in portcos that scaled on founder-led sales and never operationalized the motion.
A market fault is confirmed when: win/loss data shows consistent loss to inaction (not to competitors), deal cycles are lengthening without a clear objection pattern, and the VP's diagnosis of the problem matches what buyers are actually saying in discovery.
What This Means for Operating Partners
This situation is a governance problem before it is a talent problem. If your portfolio review cadence doesn't give you stage-level conversion data, ICP documentation, and a baseline Revenue Readiness assessment for each holding, you are making people decisions on anecdote.
Concrete moves:
- Before any personnel action, commission a structured revenue architecture audit at the portco. Scope it to four weeks. The output should be a written diagnosis mapped to the three-fault model — person, process, market — with supporting evidence from pipeline data and buyer interviews.
- Establish a Revenue Readiness Index as a portfolio standard. If you cannot compare GTM maturity across holdings on a common instrument, you cannot govern it. The index should score ICP definition, pipeline hygiene, conversion rate visibility, and retention architecture — and it should travel into board packages.
- Separate the diagnosis from the personnel conversation. Share the audit findings with the VP before any decision is made. A strong operator will engage with the data and own their part of it. That response is itself diagnostic.
- Pressure-test the market thesis independently. Don't rely solely on the VP's read. Buyer interviews conducted outside the sales process will surface positioning gaps that internal data cannot.
With exit readiness now a top-three portfolio support priority for GPs according to EY's Q2 2026 PE Pulse, the operating partners who build a repeatable diagnostic for this situation — rather than reacting to it case by case — will compress the time between identifying a revenue problem and fixing it.
FAQ
How do I know if a VP Sales hire is the problem or if they inherited a broken process?
Look at what they've built, not just what they've produced. A VP who has documented a revised ICP, introduced pipeline hygiene standards, and established a coaching cadence has done the foundational work — even if revenue hasn't moved yet. A VP who has produced none of those artifacts after nine months has not. The presence or absence of durable process outputs is a more reliable signal than revenue alone at this stage.
What's the fastest way to diagnose a stalled portco sales motion without creating leadership instability?
Frame the work as a revenue architecture audit, not a personnel review. Audit the system — ICP definition, stage-level conversion data, win/loss patterns, retention rates — before drawing any conclusions about the person. This framing is accurate, keeps the team functional, and produces evidence that makes any subsequent personnel decision defensible to the board.
When should an operating partner intervene directly in a portco's sales leadership situation?
When the portco's own diagnostic capacity is insufficient to distinguish between a person fault, a process fault, and a market fault — and when the cost of a wrong decision (either keeping a misfit or losing a capable operator) is material to the exit timeline. At that point, the operating partner's role is to bring a structured diagnostic framework and the credibility to run it without destabilizing the leadership team.